Fundraising Fox

Natera

NASDAQ: NTRA

<UNKNOWN> · Incorporated in Delaware · 8 known investors

natera.com ↗

Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.

BiotechDigital HealthHealthtechMedical Devicesin /natera@nateragenetics

Founders & leadership

MRMatthew Rabinowitz
Matthew RabinowitzCo-founder & Executive Chairman

Investors · 8

Bain Capital Life SciencesBoston
Cheyenne VenturesWoodside
Claremont Creek VenturesOakland · $500K – $3M
Foresite CapitalLarkspur
Lightspeed Venture PartnersMenlo Park · $1.7M – $87M
RA CapitalBoston
Sofinnova VenturesMenlo Park · $100K – $15M
Harmony PartnersreportedNew York

Acquisitions · 1

Early investors' stakes continue via these deals
Foresight Diagnostics

Cancer recurrence testing platform acquired by Natera.

In the news